BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AusBiotech Ltd. & Beacon to Partner on Key Investment Events


9/26/2012 9:31:18 AM

26 September 2012 -- Biotechnology industry group, AusBiotech and Beacon Events, organiser of the largest resource sector investor event in the Asia Pacific Region – Mines and Money - have today announced a partnership to deliver biotechnology investor meetings in Hong Kong and Sydney until 2015.

The Hong Kong-based Beacon Events, serves the increasingly important emerging markets of Asia, providing cutting-edge, market-driven programs and synergy with AusBiotech’s move into the fast-growing investment hub in Hong Kong. Hong Kong, with its direct access to China, is developing as a pivotal hub in the Asia Pacific region, and this is especially important from an Australian perspective as a regional neighbour. Private investment by Chinese and Hong Kong-based venture capitalists has burst forth in recent years, peaking at $1billion in 2010 and reaching $573 million in 2011. The average Chinese VC investment in life sciences in 2011 was $ 25 million, compared to $10 million in the US. Mr Glenn Cross, Chief Operating Officer at AusBiotech said: “While there are already numerous examples of Sino-Australian partnership in life sciences, evidenced in part by the 50 Hong Kong fund managers currently investing in Australian public biotech companies, we expect this interest to grow vastly in the coming years.”

“Our partnership with Beacon Event looks to its expertise in Hong Kong and providing finance and investment events for the resources sector, which is naturally converging with biotechnology as it shares the same investor profile.”

Daniel Kirwin, Chief Executive of Beacon said: “We are delighted to be working with AusBiotech in Australia and Asia. Our combined efforts and expertise will produce world class large scale events for the biotechnology sector.”

“The inaugural Hong Kong invest event in June 2013 will be well placed to deliver investment, education and networking opportunities. We expect it to be the must-attend event in Asia region.”

The first event, AsiaBiotech Invest, will bring together the most influential decision makers, from within international biotech companies, the investment community, governments and professional services.

3 – 5 June 2013 at Sheraton Hong Kong Hotel & Towers, Kowloon, Hong Kong

For further media information and interviews, please contact: Lorraine Chiroiu, AusBiotech, Communication Manager, +61 (0) 429 801 118 or lchiroiu@ausbiotech.org

For further information in regard to Beacon Events, please contact: Daniel Kirwin, Chief Executive at daniel.kirwin@beaconevents.com

For further information in regard to AusBiotech Investment, please contact: Hayley Laing, AusBiotech, Investment Program Manager at hlaing@ausbiotech.org

About AusBiotech and AusBiotech Investment

AusBiotech is Australia's biotechnology industry organisation working on behalf of over 3,000 members in the areas of human health, medical devices, food technology, agriculture, environmental and industrial biotechnology, for more than 25 years. AusBiotech is dedicated to the development, growth and prosperity of the Australian biotechnology industry.

AusBiotech Investment offers a comprehensive series of national and international investor events as a global platform for Australian life sciences companies to showcase their company’s offering for partnership and investment.

About Beacon Events

Beacon is a major conference and exhibition organiser producing first class international events that meet the challenges facing major business sectors today – including specialising in finance and investment events. Beacon’s focus is on large-scale, must-attend events that are independently researched and tailored to deliver unbiased and focused market information.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES